NK Cell Therapy Market - Global Outlook and Forecast 2022-2028

January 2022 | 74 pages | ID: NA9DFBBB4EFAEN
Market Monitor Global

Abstracts

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.

This report contains market size and forecasts of NK Cell Therapy in Global, including the following market information:

Global NK Cell Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global NK Cell Therapy market was valued at 357.9 million in 2021 and is projected to reach US$ 981.5 million by 2028, at a CAGR of 15.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

NK Cell Therapies Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of NK Cell Therapy include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma and NantWorks, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the NK Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global NK Cell Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global NK Cell Therapy Market Segment Percentages, by Type, 2021 (%)

• NK Cell Therapies
• NK Cell Directed Antibodies

Global NK Cell Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global NK Cell Therapy Market Segment Percentages, by Application, 2021 (%)

• Cancer
• Gastrointestinal Diseases
• Others

Global NK Cell Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global NK Cell Therapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies NK Cell Therapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies NK Cell Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Nektar Therapeutics
• Innate Pharma SA
• Affimed
• Chipscreen Biosciences
• Fate Therapeutics
• Glycostem Therapeutics
• Dragonfly Therapeutics
• Kiadis Pharma
• NantWorks
• Nkarta Therapeutics
• Fortress Biotech

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 NK Cell Therapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global NK Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NK CELL THERAPY OVERALL MARKET SIZE

2.1 Global NK Cell Therapy Market Size: 2021 VS 2028
2.2 Global NK Cell Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top NK Cell Therapy Players in Global Market
3.2 Top Global NK Cell Therapy Companies Ranked by Revenue
3.3 Global NK Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 NK Cell Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies NK Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 NK Cell Therapy Players in Global Market
  3.6.1 List of Global Tier 1 NK Cell Therapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 NK Cell Therapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global NK Cell Therapy Market Size Markets, 2021 & 2028
  4.1.2 NK Cell Therapies
  4.1.3 NK Cell Directed Antibodies
4.2 By Type - Global NK Cell Therapy Revenue & Forecasts
  4.2.1 By Type - Global NK Cell Therapy Revenue, 2017-2022
  4.2.2 By Type - Global NK Cell Therapy Revenue, 2023-2028
  4.2.3 By Type - Global NK Cell Therapy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global NK Cell Therapy Market Size, 2021 & 2028
  5.1.2 Cancer
  5.1.3 Gastrointestinal Diseases
  5.1.4 Others
5.2 By Application - Global NK Cell Therapy Revenue & Forecasts
  5.2.1 By Application - Global NK Cell Therapy Revenue, 2017-2022
  5.2.2 By Application - Global NK Cell Therapy Revenue, 2023-2028
  5.2.3 By Application - Global NK Cell Therapy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global NK Cell Therapy Market Size, 2021 & 2028
6.2 By Region - Global NK Cell Therapy Revenue & Forecasts
  6.2.1 By Region - Global NK Cell Therapy Revenue, 2017-2022
  6.2.2 By Region - Global NK Cell Therapy Revenue, 2023-2028
  6.2.3 By Region - Global NK Cell Therapy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America NK Cell Therapy Revenue, 2017-2028
  6.3.2 US NK Cell Therapy Market Size, 2017-2028
  6.3.3 Canada NK Cell Therapy Market Size, 2017-2028
  6.3.4 Mexico NK Cell Therapy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe NK Cell Therapy Revenue, 2017-2028
  6.4.2 Germany NK Cell Therapy Market Size, 2017-2028
  6.4.3 France NK Cell Therapy Market Size, 2017-2028
  6.4.4 U.K. NK Cell Therapy Market Size, 2017-2028
  6.4.5 Italy NK Cell Therapy Market Size, 2017-2028
  6.4.6 Russia NK Cell Therapy Market Size, 2017-2028
  6.4.7 Nordic Countries NK Cell Therapy Market Size, 2017-2028
  6.4.8 Benelux NK Cell Therapy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia NK Cell Therapy Revenue, 2017-2028
  6.5.2 China NK Cell Therapy Market Size, 2017-2028
  6.5.3 Japan NK Cell Therapy Market Size, 2017-2028
  6.5.4 South Korea NK Cell Therapy Market Size, 2017-2028
  6.5.5 Southeast Asia NK Cell Therapy Market Size, 2017-2028
  6.5.6 India NK Cell Therapy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America NK Cell Therapy Revenue, 2017-2028
  6.6.2 Brazil NK Cell Therapy Market Size, 2017-2028
  6.6.3 Argentina NK Cell Therapy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa NK Cell Therapy Revenue, 2017-2028
  6.7.2 Turkey NK Cell Therapy Market Size, 2017-2028
  6.7.3 Israel NK Cell Therapy Market Size, 2017-2028
  6.7.4 Saudi Arabia NK Cell Therapy Market Size, 2017-2028
  6.7.5 UAE NK Cell Therapy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Nektar Therapeutics
  7.1.1 Nektar Therapeutics Corporate Summary
  7.1.2 Nektar Therapeutics Business Overview
  7.1.3 Nektar Therapeutics NK Cell Therapy Major Product Offerings
  7.1.4 Nektar Therapeutics NK Cell Therapy Revenue in Global Market (2017-2022)
  7.1.5 Nektar Therapeutics Key News
7.2 Innate Pharma SA
  7.2.1 Innate Pharma SA Corporate Summary
  7.2.2 Innate Pharma SA Business Overview
  7.2.3 Innate Pharma SA NK Cell Therapy Major Product Offerings
  7.2.4 Innate Pharma SA NK Cell Therapy Revenue in Global Market (2017-2022)
  7.2.5 Innate Pharma SA Key News
7.3 Affimed
  7.3.1 Affimed Corporate Summary
  7.3.2 Affimed Business Overview
  7.3.3 Affimed NK Cell Therapy Major Product Offerings
  7.3.4 Affimed NK Cell Therapy Revenue in Global Market (2017-2022)
  7.3.5 Affimed Key News
7.4 Chipscreen Biosciences
  7.4.1 Chipscreen Biosciences Corporate Summary
  7.4.2 Chipscreen Biosciences Business Overview
  7.4.3 Chipscreen Biosciences NK Cell Therapy Major Product Offerings
  7.4.4 Chipscreen Biosciences NK Cell Therapy Revenue in Global Market (2017-2022)
  7.4.5 Chipscreen Biosciences Key News
7.5 Fate Therapeutics
  7.5.1 Fate Therapeutics Corporate Summary
  7.5.2 Fate Therapeutics Business Overview
  7.5.3 Fate Therapeutics NK Cell Therapy Major Product Offerings
  7.5.4 Fate Therapeutics NK Cell Therapy Revenue in Global Market (2017-2022)
  7.5.5 Fate Therapeutics Key News
7.6 Glycostem Therapeutics
  7.6.1 Glycostem Therapeutics Corporate Summary
  7.6.2 Glycostem Therapeutics Business Overview
  7.6.3 Glycostem Therapeutics NK Cell Therapy Major Product Offerings
  7.6.4 Glycostem Therapeutics NK Cell Therapy Revenue in Global Market (2017-2022)
  7.6.5 Glycostem Therapeutics Key News
7.7 Dragonfly Therapeutics
  7.7.1 Dragonfly Therapeutics Corporate Summary
  7.7.2 Dragonfly Therapeutics Business Overview
  7.7.3 Dragonfly Therapeutics NK Cell Therapy Major Product Offerings
  7.7.4 Dragonfly Therapeutics NK Cell Therapy Revenue in Global Market (2017-2022)
  7.7.5 Dragonfly Therapeutics Key News
7.8 Kiadis Pharma
  7.8.1 Kiadis Pharma Corporate Summary
  7.8.2 Kiadis Pharma Business Overview
  7.8.3 Kiadis Pharma NK Cell Therapy Major Product Offerings
  7.8.4 Kiadis Pharma NK Cell Therapy Revenue in Global Market (2017-2022)
  7.8.5 Kiadis Pharma Key News
7.9 NantWorks
  7.9.1 NantWorks Corporate Summary
  7.9.2 NantWorks Business Overview
  7.9.3 NantWorks NK Cell Therapy Major Product Offerings
  7.9.4 NantWorks NK Cell Therapy Revenue in Global Market (2017-2022)
  7.9.5 NantWorks Key News
7.10 Nkarta Therapeutics
  7.10.1 Nkarta Therapeutics Corporate Summary
  7.10.2 Nkarta Therapeutics Business Overview
  7.10.3 Nkarta Therapeutics NK Cell Therapy Major Product Offerings
  7.10.4 Nkarta Therapeutics NK Cell Therapy Revenue in Global Market (2017-2022)
  7.10.5 Nkarta Therapeutics Key News
7.11 Fortress Biotech
  7.11.1 Fortress Biotech Corporate Summary
  7.11.2 Fortress Biotech Business Overview
  7.11.3 Fortress Biotech NK Cell Therapy Major Product Offerings
  7.11.4 Fortress Biotech NK Cell Therapy Revenue in Global Market (2017-2022)
  7.11.5 Fortress Biotech Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. NK Cell Therapy Market Opportunities & Trends in Global Market
Table 2. NK Cell Therapy Market Drivers in Global Market
Table 3. NK Cell Therapy Market Restraints in Global Market
Table 4. Key Players of NK Cell Therapy in Global Market
Table 5. Top NK Cell Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global NK Cell Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global NK Cell Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies NK Cell Therapy Product Type
Table 9. List of Global Tier 1 NK Cell Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 NK Cell Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global NK Cell Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - NK Cell Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - NK Cell Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global NK Cell Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - NK Cell Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - NK Cell Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global NK Cell Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global NK Cell Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global NK Cell Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America NK Cell Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America NK Cell Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe NK Cell Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe NK Cell Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia NK Cell Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia NK Cell Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America NK Cell Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America NK Cell Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa NK Cell Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa NK Cell Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Nektar Therapeutics Corporate Summary
Table 31. Nektar Therapeutics NK Cell Therapy Product Offerings
Table 32. Nektar Therapeutics NK Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 33. Innate Pharma SA Corporate Summary
Table 34. Innate Pharma SA NK Cell Therapy Product Offerings
Table 35. Innate Pharma SA NK Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Affimed Corporate Summary
Table 37. Affimed NK Cell Therapy Product Offerings
Table 38. Affimed NK Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 39. Chipscreen Biosciences Corporate Summary
Table 40. Chipscreen Biosciences NK Cell Therapy Product Offerings
Table 41. Chipscreen Biosciences NK Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 42. Fate Therapeutics Corporate Summary
Table 43. Fate Therapeutics NK Cell Therapy Product Offerings
Table 44. Fate Therapeutics NK Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 45. Glycostem Therapeutics Corporate Summary
Table 46. Glycostem Therapeutics NK Cell Therapy Product Offerings
Table 47. Glycostem Therapeutics NK Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 48. Dragonfly Therapeutics Corporate Summary
Table 49. Dragonfly Therapeutics NK Cell Therapy Product Offerings
Table 50. Dragonfly Therapeutics NK Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 51. Kiadis Pharma Corporate Summary
Table 52. Kiadis Pharma NK Cell Therapy Product Offerings
Table 53. Kiadis Pharma NK Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 54. NantWorks Corporate Summary
Table 55. NantWorks NK Cell Therapy Product Offerings
Table 56. NantWorks NK Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 57. Nkarta Therapeutics Corporate Summary
Table 58. Nkarta Therapeutics NK Cell Therapy Product Offerings
Table 59. Nkarta Therapeutics NK Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 60. Fortress Biotech Corporate Summary
Table 61. Fortress Biotech NK Cell Therapy Product Offerings
Table 62. Fortress Biotech NK Cell Therapy Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. NK Cell Therapy Segment by Type in 2021
Figure 2. NK Cell Therapy Segment by Application in 2021
Figure 3. Global NK Cell Therapy Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global NK Cell Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global NK Cell Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by NK Cell Therapy Revenue in 2021
Figure 8. By Type - Global NK Cell Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global NK Cell Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global NK Cell Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America NK Cell Therapy Revenue Market Share, 2017-2028
Figure 12. US NK Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada NK Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico NK Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe NK Cell Therapy Revenue Market Share, 2017-2028
Figure 16. Germany NK Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France NK Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. NK Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy NK Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia NK Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries NK Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux NK Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia NK Cell Therapy Revenue Market Share, 2017-2028
Figure 24. China NK Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan NK Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea NK Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia NK Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India NK Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America NK Cell Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil NK Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina NK Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa NK Cell Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey NK Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel NK Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia NK Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE NK Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Nektar Therapeutics NK Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Innate Pharma SA NK Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Affimed NK Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Chipscreen Biosciences NK Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Fate Therapeutics NK Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Glycostem Therapeutics NK Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Dragonfly Therapeutics NK Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Kiadis Pharma NK Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. NantWorks NK Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Nkarta Therapeutics NK Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Fortress Biotech NK Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)